WallStreetZenWallStreetZen

NASDAQ: TNGX
Tango Therapeutics Inc Stock Ownership - Who owns Tango Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Tango Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Third Rock Ventures IV LP10% Owner2025-09-25500,000$8.02
$4.01MSell
Third Rock Ventures IV LP10% Owner2025-09-16363,541$7.04
$2.56MSell
Third Rock Ventures IV LP10% Owner2025-09-0886,459$7.04
$608.67kSell
Third Rock Ventures IV LP10% Owner2025-09-05642,906$7.00
$4.50MSell
Third Rock Ventures IV LP10% Owner2025-08-22302,194$7.00
$2.12MSell
Third Rock Ventures IV LP10% Owner2025-08-191,100,000$7.01
$7.71MSell
Barbara WeberChief Executive Officer2025-02-059,013$3.16
$28.49kSell
Douglas BarryGeneral Counsel2025-02-052,556$3.16
$8.08kSell
Adam CrystalPresident Research Development2025-02-056,851$3.16
$21.66kSell
Daniella BeckmanChief Financial Officer2025-02-053,948$3.16
$12.48kSell

1 of 2

TNGX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TNGX insiders and whales buy or sell their stock.

TNGX Shareholders

What type of owners hold Tango Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ecor1 Capital LLC21.54%23,961,472$179.59MInsider
Trv GP IV LLC15.15%16,859,075$126.36MInstitution
Boxer Capital LLC13.65%15,187,092$113.83MInsider
Third Rock Ventures IV LP12.46%13,863,975$103.91MInsider
Boxer Capital Management LLC12.29%13,679,092$102.52MInsider
Tcg Crossover Management LLC9.65%10,736,000$80.47MInstitution
Ecor1 Capital LLC9.55%10,630,736$79.68MInstitution
Boxer Capital Management LLC8.78%9,771,485$73.24MInstitution
Farallon Capital Management LLC8.23%9,157,000$68.63MInstitution
Aaron I. Davis6.29%6,993,450$52.42MInsider

1 of 3

TNGX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TNGX60.44%39.56%Net SellingNet Selling
RZLT42.15%57.85%Net Buying
ABUS29.81%70.19%Net Selling
VIR67.84%32.16%Net SellingNet Selling
INBX71.80%28.20%Net SellingNet Selling
View Top Biotech Stocks

Tango Therapeutics Stock Ownership FAQ

Who owns Tango Therapeutics?

Tango Therapeutics (NASDAQ: TNGX) is owned by 114.38% institutional shareholders, 74.85% Tango Therapeutics insiders, and 0.00% retail investors. Ecor1 Capital LLC is the largest individual Tango Therapeutics shareholder, owning 23.96M shares representing 21.54% of the company. Ecor1 Capital LLC's Tango Therapeutics shares are currently valued at $179.59M.

If you're new to stock investing, here's how to buy Tango Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.